Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Rock Springs Capital Management LP
Form 13F · Q2 2026

Rock Springs Capital Management LP

CIK 1595725Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.0B
Reported book value
104
Positions
12
Quarters on record
Top 50
Positions

Rock Springs Capital Management LP — holdings

Top 50 positions of 104, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc1.1M−8.6%$207M10.1%
2TVTX Travere Therapeutics Inc2.2M+47.4%$124M6.0%
3LLY Eli Lilly & Co98,700+0.0%$118M5.8%
4MDGL Madrigal Pharmaceuticals Inc174,999+2.3%$94M4.6%
5MIRM Mirum Pharmaceuticals Inc798,145−1.6%$93M4.6%
6RYTM Rhythm Pharmaceuticals Inc692,598+0.4%$77M3.8%
7KYMR Kymera Therapeutics Inc453,156−8.8%$52M2.5%
8ARGX Argenx Se52,750−46.4%$49M2.4%
9ASND Ascendis Pharma A/S168,750—$45M2.2%
10XENE Xenon Pharmaceuticals Inc683,907−10.4%$41M2.0%
11SRRK Scholar Rock Hldg Corp715,452−3.3%$39M1.9%
12INSM Insmed Inc362,150+15.2%$39M1.9%
13PEN Penumbra Inc115,750−3.9%$37M1.8%
14GPCR Structure Therapeutics Inc640,317+0.0%$34M1.7%
15RARE Ultragenyx Pharmaceutical In967,855−20.6%$32M1.6%
16IRTC Irhythm Holdings Inc269,650+3.0%$32M1.6%
17ISRG Intuitive Surgical Inc76,460−6.8%$30M1.5%
18AGL Agilon Health Inc262,600+1.0%$28M1.4%
19UNH Unitedhealth Group Inc63,750+20.3%$26M1.3%
20CLDX Celldex Therapeutics Inc New699,146+7.5%$26M1.3%
21ERAS Erasca Inc1.4M+27.1%$26M1.3%
22NBIX Neurocrine Biosciences Inc144,750−3.8%$24M1.2%
23ELVN Enliven Therapeutics Inc464,625−43.8%$24M1.2%
24THC Tenet Healthcare Corp125,000+0.0%$23M1.1%
25DXCM Dexcom Inc343,000−3.5%$23M1.1%
26ACRS Aclaris Therapeutics Inc4.3M−3.2%$23M1.1%
27MMED Minimed Group Inc1.5M+44.1%$23M1.1%
28BSX Boston Scientific Corp528,500+2.6%$23M1.1%
29PHVS Pharvaris N V648,333+0.4%$22M1.1%
30AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc662,918—$22M1.1%
31COAG Hemab Therapeutics Hldgs Inc575,432—$21M1.0%
32DYN Dyne Therapeutics Inc942,154−3.1%$21M1.0%
33ALNY Alnylam Pharmaceuticals Inc66,750−9.8%$20M1.0%
34COGT Cogent Biosciences Inc515,917−17.3%$20M1.0%
35AGIO Agios Pharmaceuticals Inc532,563−33.4%$20M1.0%
36NAMS Newamsterdam Pharma Company582,744−1.0%$20M1.0%
37VERA Vera Therapeutics Inc427,584−15.1%$18M0.9%
38TARS Tarsus Pharmaceuticals Inc277,087+23.1%$17M0.9%
39HTFL Heartflow Inc573,500+0.2%$17M0.8%
40MBX Mbx Biosciences Inc298,218+3.6%$16M0.8%
41CYTK Cytokinetics Inc187,980+314.4%$16M0.8%
42BCAX Bicara Therapeutics Inc535,286+9.4%$16M0.8%
43PBLS Parabilis Medicines Inc578,028—$16M0.8%
44ZLAB Zai Lab Ltd814,707+0.0%$15M0.8%
45DANAHER CORP DEL Danaher Corp Del76,300+24.1%$15M0.7%
46TNGX Tango Therapeutics Inc456,551+18.0%$14M0.7%
47EVH Evolent Health Inc2.5M−6.5%$14M0.7%
48PTCT Ptc Therapeutics Inc162,298+0.3%$13M0.6%
49MLYS Mineralys Therapeutics Inc484,951+10.3%$13M0.6%
50ZBIO Zenas Biopharma Inc502,077+0.0%$13M0.6%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.